Canary

Jane

Injective

<p>Canary Capital (<a href="https://x.com/CanaryFunds" rel="noopener noreferrer nofollow">@CanaryFunds</a>) has moved its planned staked Injective ETF to Nasdaq under the ticker INJC, according to a fourth amended registration statement filed with the U.S. Securities and Exchange Commission (SEC) on Friday. The fund, formally named the Canary Staked INJ ETF, would hold Injective's native token, <a href="https://x.com/search?q=%24INJ&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$INJ</a>, and stake at least 90% of it.</p>
<h2 id="fee-structure-and-staking-terms">Fee structure and staking terms</h2>
<p>The fund would charge a 1.10% annual fee. It would also pay 30% of its staking rewards in staking fees. An earlier amendment listed the exchange as Cboe BZX. <a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126021228/canary-s1a_092426.htm" rel="noopener noreferrer nofollow">The September 24 filing</a> states the shares would trade on Cboe BZX, while <a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126023446/inj-s1a_102326.htm" rel="noopener noreferrer nofollow">the October 23 amendment</a> names The Nasdaq Stock Market LLC as the exchange.</p>
<p>According to the prospectus, the trust's primary objective is to provide exposure to the price of INJ, less expenses. A secondary objective is to earn additional INJ through a staking program administered by the sponsor, with rewards earned by validating transactions on the Injective proof-of-stake blockchain.</p>
<h2 id="seed-investment-and-trading-partners">Seed investment and trading partners</h2>
<p>The Injective Foundation plans to buy up to $15M of shares at the start, paid in INJ. Jane Street, Cumberland and Flowdesk are among the fund's named trading partners.</p>
<p>The fund cannot begin trading until the SEC signs off. As <a href="https://www.tokenpost.com/news/regulation/24195" rel="noopener noreferrer nofollow">TokenPost reported</a> on an earlier amendment, a registration statement does not by itself authorize an ETF to launch or begin trading.</p>
<p>Canary is not the only issuer pursuing an INJ product. <a href="https://cryptobriefing.com/injective-inj-injc-staked-etf-filing/" rel="noopener noreferrer nofollow">Crypto Briefing reported</a> that at least three INJ-related ETF applications are pending with the SEC, including proposals from 21Shares and REX-Osprey alongside Canary's.</p>
<h2 id="sources">Sources</h2>
<p><a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126023446/inj-s1a_102326.htm" rel="noopener noreferrer nofollow">SEC: Canary Staked INJ ETF Form S-1/A (October 23, 2026)</a><br><a href="https://www.sec.gov/Archives/edgar/data/0002073616/000199937126023446/ex5-1.htm" rel="noopener noreferrer nofollow">SEC: Canary Staked INJ ETF Amendment No. 4 legal opinion</a><br><a href="https://cryptobriefing.com/injective-inj-injc-staked-etf-filing/" rel="noopener noreferrer nofollow">Crypto Briefing: Injective's INJ heads toward Wall Street with proposed INJC staking ETF</a></p>

Canary Capital’s staked Injective ETF gets its launch details

目录

BSCN

发布于 2026年10月27日的其他文章

订阅我们免费的电子期刊，获取每日最新加密领域动态！

Canary Capital’s staked Injective ETF gets its launch details

目录

BSCN

发布于 2026年10月27日 的其他文章

订阅我们免费的电子期刊，获取每日最新加密领域动态！

发布于 2026年10月27日的其他文章